Patterns of prescribing and utilization of asthma medications in a tertiary hospital in Dubai, United Arab Emirates


Autoria(s): Fahmy, Sahar A.; Abu-Gharbieh, Eman; Hamidi, Samer
Cobertura

Origin of publication: Nigeria

Data(s)

07/06/2016

Resumo

Purpose: To assess the prescribing patterns of asthma medications in a hospital in Dubai, United Arab Emirates (UAE) with regard to the demographic pattern of the population. Methods: One hundred fifty four patients, 83 male and 71 female, were randomly selected from the outpatient respiratory diseases clinic of a tertiary hospital in Dubai, UAE over a 3-month period. Patients were asked to complete a structured questionnaire and data were analyzed using STATA 12 software. Results: Most of the patients were within the age range of 0 – 10 years. About 86 % of the patients were overweight. Half of the patients were non-smokers while 51 % of them had a family history of asthma. About 54 % of the patients received multiple drug therapy of which two-drug combinations were widely prescribed (31 %). The most utilized drug classes were short acting β-agonists (42 %), xanthine drugs (16 %), leukotriene modifiers (14 %) and oral and intravenous corticosteroids (13 %). Statistical significant differences among the age groups (F = 2.33, p = 0.0275) were found. Conclusion: Primary prevention to reduce the level of exposure to common risk factors for asthma would be a vital step to control the disease. More resources should be channeled into educating physicians and patients on rational drug utilization to improve the quality of patients’ care.

Formato

html

Identificador

http://www.bioline.org.br/abstract?id=pr16142

Idioma(s)

en

Publicador

Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria

Relação

http://www.tjpr.org; http://www.bioline.org.br/pr

Direitos

Copyright 2016 - Tropical Journal of Pharmaceutical Research

Fonte

Tropical Journal of Pharmaceutical Research (ISSN: 1596-5996) Vol 15 Num 5

Palavras-Chave #Asthma; β-agonists; Leukotriene modifiers; utilization of medicines; Xanthines; Rational drug utilization
Tipo

AA